-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/npsd/Generic_Dashboard_Data_2023.xlsx
January 01, 2023 - -64 years) Male Unknown Harm 111 3,530 3.1%
Blood or Blood Product Adult (18-64 years) Unknown Death … adult (65-74 years) Male No Harm 1,003 1,454 69.0%
Blood or Blood Product Mature adult (65-74 years … years) Male Mild Harm 307 1,109 27.7%
Blood or Blood Product Older adult (75-84 years) Male No Harm … Aged adult (85+ years) Female Death 1 786 0.1%
Blood or Blood Product Aged adult (85+ years) Female … Aged adult (85+ years) Unknown Moderate Harm 5 101 5.0%
Blood or Blood Product Aged adult (85+ years
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/npsd/Medications_Supplement_Dashboard_Data_2023.xlsx
January 01, 2023 - (85+ years) No 640 13.3%
Aged adult (85+ years) Unknown 88 1.8%
Aged adult (85+ years) Yes 4,094 84.9% … (65-74 years) Yes 13,779 87.7%
Older adult (75-84 years) No 1,304 12.6%
Older adult (75-84 years) … ) Communication 2,367 5.0%
Adult (18-64 years) Data 1,183 2.5%
Adult (18-64 years) Environment 169 … (85+ years) Environment 12 0.2%
Aged adult (85+ years) Human Factors 620 10.5%
Aged adult (85+ years … (65-74 years) Data 497 2.8%
Mature adult (65-74 years) Environment 74 0.4%
Mature adult (65-74 years
-
www.qualitymeasures.ahrq.gov/data/visualizations/ed-visit-suicidal-ideation.html
February 01, 2021 - presents statistics on ED visits related to suicidal ideation or suicide attempt among individuals age 5 years … visits per 100,000 population related to suicidal ideation or suicide attempt for individuals ages 5-24 years … , 25-64 years, and 65+ years.
-
www.qualitymeasures.ahrq.gov/cahps/about-cahps/25timeline.html
April 01, 2024 - Assessment of Healthcare Providers and Systems (CAHPS®)
About CAHPS
Celebrating 25 Years … Patient Experience
CAHPS Announcements
Contact CAHPS
Celebrating 25 Years … of the CAHPS Program
For 25 years, AHRQ has developed evidence-based surveys to support healthcare … homes
Care for specific health conditions
Health plans and related programs
Access CAHPS ® : 25 Years … reviewed April 2024
Page originally created October 2020
Internet Citation: Celebrating 25 Years
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-164-materials-vi-a.pdf
March 09, 2017 - 7 years 252,360 182,914 72.5% 67,567 36.9% 64,464 35.2% 52,907 28.9% 1,300 0.7% 541
8 years 242,915 … 0.4% 380
12 years 218,152 157,969 72.4% 61,099 38.7% 42,208 26.7% 18,861 11.9% 360 0.2% 276
13 years … years 184,371 116,226 63.0% 19,356 16.7% 1,013 0.9% 255 0.2% 10 0.0% 89
18 years 173,561 53,720 31.0% … 212
5 years 60,879 70,281 34.6% 103 50,472 55,741 27.5% 21 1,343 2,090 1.0% 11 157
6 years 57,026 … 13 years 24,633 30,372 20.1% 40 8,566 10,590 7.0% 11 231 338 0.2% 1 23
14 years 10,760 15,848 11.1%
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-202-tech-specs.pdf
October 11, 2018 - Parents' Evaluation of Developmental Status (PEDS), birth - 8 years
Non-recommended tools are those … " using "Ages and
Stages Questionnaire (ASQ), 2 months - 5 years User Defined QDM Value Set (1.1.1.1) … "
using "Bayley Infant Neuro-developmental Screen (BINS), 3 months - 2 years User Defined QDM Value Set … " using "Child
Development Inventory (CDI), 18 months - 6 years User Defined QDM Value Set (1.1.1.1)" … " using "Child Development Review-Parent Questionnaire (CDR-PQ), 18 months - 5 years User
Defined QDM
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-appendix-2.pdf
January 17, 2024 - CORTICOSTEROIDS (ICS)
ICS NDC Code Brand Name Generic Product Name Route Drug ID Device
FDA-Age
(Years … and
older N N N Y
ICS NDC Code Brand Name Generic Product Name Route Drug ID Device
FDA-Age
(Years … Budesonide
budesonide 0.5 mg/2 mL
inhalation suspension inhalation d04276 Nebulizer
12 mon –
8 years … Budesonide
budesonide 0.5 mg/2 mL
inhalation suspension inhalation d04276 Nebulizer
12 mon –
8 years … and
older N N N Y
ICS NDC Code Brand Name Generic Product Name Route Drug ID Device
FDA-Age
(Years
-
www.qualitymeasures.ahrq.gov/research/findings/nhqrdr/2014chartbooks/womenhealth/wm-hl2.html
September 01, 2015 - with 3 doses of either HPV2 or HPV4, which can be started at age 9 years, with catchup vaccinations … at later ages for females (13-26 years). … Overall Rate: In 2012, the percentage of adolescent females ages 13-15 years who received 3 or more … From 2008 to 2012, the percentage of adolescent females ages 13-15 years who received 3 or more doses … HPV Vaccine Among Adolescent Females Ages 16-17
Adolescent females ages 16-17 years who received 3
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-section-2-technical-specs.pdf
May 23, 2014 - 1-5 years
6-11 years
12-17 years
18-20 years
Total
The total is the sum of the age … Daily Dose
Criteria 13-17 years
Average Daily Dose
Criteria 18-20 years
Asenapine Maleate >20 … Average Daily
Dose Criteria
10-12 years
Average Daily Dose
Criteria 13-17 years
Average Daily … Report three
age stratifications and a total rate:
1–5 years.
6–11 years.
12–17 years. … Average Daily
Dose Criteria for
10 12 years
Average Daily Dose Criteria for 13 17
years
Aripiprazole
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/measure_retirement/supplemental-materials/supplementaldoc2.pdf
September 01, 2014 - 3 years:
28% (5)
Enrollees age
1 year:
19, 61
Age 2 years:
23, 50
Age 3 years:
18, 35 … Chlamydia
Screening
(females ages 16–
20 years)
Sexually
active females
ages 16–20
years (MAX … Adolescent
Well-Care Visits:
Persons Ages 12–
21 Years
Enrollees
ages 12–17
years (MAX
b
): … –6
years: 86, 92
Ages 7–11
years: 86, 93
Ages 12–19
years: 86, 92
Enrollees
ages 12–24 … months:
Mixed
Ages 25
months–6
years:
Downward
Ages 7–11
years: Mixed
Ages 12–19
years
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-230-tech-specs.pdf
July 12, 2019 - CHIPRA 230: Technical Specifications
1
The percentage of children, ages 2 through 17 years … For children
≥16 years of age, BMI score is sufficient. … Weight Classification Using BMI percentile, children 2 through 17 years of age can be classified
into … Ages 2 through 17 years of age. … BMI score qualifies if child is 16 or 17 years of age.
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-201-asthma-section-2-tech-specs.pdf
March 12, 2019 - Technical Specifications
This measure assesses the percentage of children, ages 1 through 17 years … record data and is calculated as a
percentage as follows:
Percentage of children ages 1 through 17 years … Ages Children no younger than 1 year on January 1 of the measurement year
but younger than 18 years … with (acute) exacerbation 493.92
Denominator The number of children ages 1 through 17 years … indicating cystic fibrosis or bronchiectasis (Table 2)
Specification
• Children younger than 6 years
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-157-section-6b.pdf
August 10, 2018 - Ref.
6-12 years old / 0.324d 0.322d 0.325d 0.310d 0.310d 0.309d
1-5 years old / 0.728 0.726 0.735 … Ref.
6-12 years old / 0.324d 0.322d 0.325d 0.310d 0.310d 0.309d
1-5 years old / 0.728 0.726 0.735 … Ref.
6-12 years old / 0.329d 0.327d 0.327d 0.310d 0.310d 0.309d
1-5 years old / 0.738 0.735 0.739 … Ref.
6-12 years old / 0.411d 0.411d 0.413d 0.357d 0.359d 0.359d
1-5 years old / 0.893 0.892 0.904 … Ref.
6-12 years old / 0.411d 0.411d 0.413d 0.357d 0.358d 0.359d
1-5 years old / 0.894 0.893 0.905
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/hospital/facilscanform.pdf
November 18, 2019 - Less than 1 year d. 11 to 15 years
b. 1 to 5 years e. 16 to 20 years
c. 6 to 10 years f. … 21 years or more
2. … Less than 1 year d. 11 to 15 years
b. 1 to 5 years e. 16 to 20 years
c. 6 to 10 years f. 21 … years or more
3. … Less than 1 year d. 11 to 15 years
b. 1 to 5 years e. 16 to 20 years
c. 6 to 10 years f.
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/hospital/facilscanform.doc
November 15, 2019 - Less than 1 year
(
d.
11 to 15 years
(
b.
1 to 5 years
(
e.
16 to 20 years
(
c.
6 to 10 years … (
f.
21 years or more
2. … Less than 1 year
(
d.
11 to 15 years
(b.
1 to 5 years
(
e.
16 to 20 years
(
c.
6 to 10 years
( … f.
21 years or more
3. … Less than 1 year
(
d.
11 to 15 years
(
b.
1 to 5 years
(
e.
16 to 20 years
(
c.
6 to 10 years
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/overview/background/measures-AS-1.pdf
December 16, 2010 - Numerator: For 12-24 months, 25 months-6 years: One or more visits with a primary
care physician during … For 7-11 years, 12-19 years:
One or more visits with a primary care physician during the measurement … Denominator: Members who are 12 months through 24 months, 25 months through 6
years, 7 years through … 11 years, and 12 years through 19 years of age as of
December 31 of the measurement year.
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/npsd/data/spotlights/spotlight-falls.pdf
March 01, 2023 - , the relative
percentage of falls was highest among
Aged adults (85 years or older), but
rates of … ), Adult (18-64
years), Mature Adult (65-74 years), Older adult (75-84 years), and Aged adult (85+ years … Across most years, the relative percentage of falls was highest
among Aged adults (85 years or older … -84
years)
145,248 8.9 40,355 17.0
Aged adult (85+ years) 87,679 5.4 28,195 11.9
Unknown 497,066 … ) and triple the rate
observed among Aged adults (85 years and older).
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-150-section-2-tech-specs.pdf
November 01, 2014 - Specification – State Level
Measure Description
The percentage of children and adolescents 1 to 20 years … Eligible Population
Ages 1 to 20 years by December 31 of the measurement year. … 1-5 years
6-11 years
12-17 years
18-20 years
Total. … Ages 1 year of age to 17 years as of December 31 of the measurement year. … Report three
age stratifications and a total rate:
1–5 years.
6–11 years.
12–17 years.
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-156-section-6b.pdf
January 01, 2013 - Ref.
6-12 Years Old / 0.908 0.929 0.946 0.946 0.948 0.947
1-5 Years Old / 0.795 0.809 0.775 0.774 … Ref.
6-12 Years Old / 0.906 0.928 0.944 0.944 0.947 0.947
1-5 Years Old / 0.795 0.808 0.775 0.774 … Ref.
6-12 Years Old / 0.895 0.916 0.936 0.936 0.940 0.941
1-5 Years Old / 0.788 0.800 0.772 0.771 … Ref.
6-12 years old / 0.324d 0.322d 0.325d 0.310d 0.310d 0.309d
1-5 years old / 0.729 0.727 0.735 … Ref.
6-12 years old / 0.325d 0.323d 0.325d 0.311d 0.311d 0.310d
1-5 years old / 0.731 0.729 0.737
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/toolkits/input-file-specifications.xlsx
January 01, 2014 - medical claims source table
Blank Blank Blank Note: Data for comorbidity claims cover a total of two years … had any comorbidities that involved the dermatological body system numeric (1/0) Calculated using 2 years … had any comorbidities that involved the genitourinary body system numeric (1/0) Calculated using 2 years … had any comorbidities that involved the hematological body system numeric (1/0) Calculated using 2 years … had any comorbidities that involved the immunological body system numeric (1/0) Calculated using 2 years